Dual-antibody therapy shows promise in treating metastatic colorectal cancer Post author: Post published:December 8, 2024 Post category:uncategorized Post comments:0 Comments Metastatic colorectal cancer (mCRC) remains a daunting challenge, especially after first-line treatments fail. You Might Also Like New study reveals how tumor cells evade the immune system November 6, 2024 Semaglutide proves a game-changer for kidney and heart health in diabetes patients June 25, 2024 Low-Carb Peanut Butter Granola February 9, 2024 Leave a Reply Cancel replyYou must be logged in to post a comment.